Stibophen
Chemical compound
From Wikipedia, the free encyclopedia
Stibophen is an anthelmintic originally developed by Bayer that is used as a treatment for schistosomiasis[1] by intramuscular injection. It is classified as a trivalent antimony compound. Brand names include Fouadin/Fuadin (named in honor of Fuad I of Egypt, who had enthusiastically supported its research and development).[2][3]
| Clinical data | |
|---|---|
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.007.630 |
| Chemical and physical data | |
| Formula | C12H4Na5O16S4Sb |
| Molar mass | 769.10 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Mechanism of action
Stibophen inhibits the enzyme phosphofructokinase, which the worms need for glycolysis,[4] at least partly by binding to the sulfhydryl (–SH) group of the enzyme.[5] Inhibiting glycolysis paralyzes the worms, which lose their hold on the wall of mesenteric veins and undergo hepatic shift, die, and are phagocytosed by liver cells.[citation needed]